Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)

Stock Price: $0.59
-0.0239 (-3.89%)
Updated Mar 31, 2023 08:00 PM GMT+0000
Featured app
eToro
Invest now
<p>79% of retail CFD accounts lose money</p>
Overview
Financials
Statistics
Profile
Chart
Market Cap 37.04M
Revenue 0
Gross Profit 0
Shares Out 62.66M
EPS (ttm)
PE Ratio 0.0000
Forward PE -0.2473
Dividend Rate (ttm) 0.0000
Dividend Yield 0.0000
Trading Day Mar 31
Last Price $0.59
Previous Close $0.62
Change ($) -0.0239
Change (%) -3.89%
Day's Open 0.64
Day's Range 0.5819 - 0.64
Day's Volume 816.53K
52 Week Range 0.289 - 7.49

About Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering.

Tonix's portfolio is primarily composed of central nervous system (CNS) and immunology product candidates. The CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions.

Tonix's lead CNS candidate, TNX-102 SL1, is in mid-Phase 3 development for the management of fibromyalgia, and positive data on the RELIEF Phase 3 trial were recently reported. The Company expects interim data from a second Phase 3 study, RALLY, in the third quarter of 20212 and topline data in the fourth quarter of 2021.

The immunology portfolio includes vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer, and autoimmune diseases. Tonix's lead vaccine candidate, TNX-18003, is a live replicating vaccine based on the horsepox viral vector platform to protect against COVID-19, primarily by eliciting a T cell response.

Tonix reported positive efficacy data from animal studies of TNX-1800 in the first quarter of 2021. TNX-8013, live horsepox virus vaccine for percutaneous administration, is in development to protect against smallpox and monkeypox.

News

Quick info

Country
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Employees
73
CEO
Seth Lederman
Address
26 Main Street, Suite 101
Chatham
New Jersey
07928
Phone
12129809155
Ticker Symbol
TNXP
Reporting Currency
USD